Literature DB >> 19517103

Genetic basis of renal cellular dysfunction and the formation of kidney stones.

Saeed R Khan1, Benjamin K Canales.   

Abstract

Nephrolithiasis is a result of formation and retention of crystals within the kidneys. The driving force behind crystal formation is urinary supersaturation with respect to the stone-forming salts, which means that crystals form when the concentrations of participating ions are higher than the thermodynamic solubility for that salt. Levels of supersaturation are kept low and under control by proper functioning of a variety of cells including those that line the renal tubules. It is our hypothesis that crystal deposition, i.e., formation and retention in the kidneys, is a result of impaired cellular function, which may be intrinsic and inherent or triggered by external stimuli and challenges. Cellular impairment or dysfunction affects the supersaturation, by influencing the excretion of participating ions such as calcium, oxalate and citrate and causing hypercalciuria, hyperoxaluria or hypocitraturia. The production and excretion of macromolecular promoters and inhibitors of crystallization is also dependent upon proper functioning of the renal epithelial cells. Insufficient or ineffective crystallization modulators such as osteopontin, Tamm-Horsfall protein, bikunin, etc. are most likely produced by the impaired cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19517103      PMCID: PMC3625631          DOI: 10.1007/s00240-009-0201-9

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  110 in total

1.  Distribution of transcellular calcium and sodium transport pathways along mouse distal nephron.

Authors:  J Loffing; D Loffing-Cueni; V Valderrabano; L Kläusli; S C Hebert; B C Rossier; J G Hoenderop; R J Bindels; B Kaissling
Journal:  Am J Physiol Renal Physiol       Date:  2001-12

2.  Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats.

Authors:  David A Bushinsky; John R Asplin; Marc D Grynpas; Andrew P Evan; Walter R Parker; Kristen M Alexander; Fredric L Coe
Journal:  Kidney Int       Date:  2002-03       Impact factor: 10.612

3.  WNK4 enhances TRPV5-mediated calcium transport: potential role in hypercalciuria of familial hyperkalemic hypertension caused by gene mutation of WNK4.

Authors:  Yi Jiang; William B Ferguson; Ji-Bin Peng
Journal:  Am J Physiol Renal Physiol       Date:  2006-10-03

4.  Association of human aging with a functional variant of klotho.

Authors:  Dan E Arking; Alice Krebsova; Milan Macek; Milan Macek; Albert Arking; I Saira Mian; Linda Fried; Ada Hamosh; Srabani Dey; Iain McIntosh; Harry C Dietz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-15       Impact factor: 11.205

5.  Distal renal tubular acidosis in mice lacking the AE1 (band3) Cl-/HCO3- exchanger (slc4a1).

Authors:  Paul A Stehberger; Boris E Shmukler; Alan K Stuart-Tilley; Luanne L Peters; Seth L Alper; Carsten A Wagner
Journal:  J Am Soc Nephrol       Date:  2007-04-04       Impact factor: 10.121

6.  Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis.

Authors:  Stefanie Weber; Linda Schneider; Melanie Peters; Joachim Misselwitz; Gabriele Rönnefarth; Michael Böswald; Klaus E Bonzel; Tomas Seeman; Tereza Suláková; Eberhard Kuwertz-Bröking; Alojz Gregoric; Jean-Bernard Palcoux; Velibor Tasic; Friedrich Manz; Karl Schärer; Hannsjörg W Seyberth; Martin Konrad
Journal:  J Am Soc Nephrol       Date:  2001-09       Impact factor: 10.121

7.  R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria.

Authors:  G Vezzoli; A Terranegra; T Arcidiacono; R Biasion; D Coviello; M L Syren; V Paloschi; S Giannini; G Mignogna; A Rubinacci; A Ferraretto; D Cusi; G Bianchi; L Soldati
Journal:  Kidney Int       Date:  2007-02-28       Impact factor: 10.612

8.  Identification and characterization of a gene with base substitutions associated with the absorptive hypercalciuria phenotype and low spinal bone density.

Authors:  Berenice Y Reed; William L Gitomer; Howard J Heller; Ming Chue Hsu; Martha Lemke; Paulette Padalino; Charles Y C Pak
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

9.  Associations between renal sodium-citrate cotransporter (hNaDC-1) gene polymorphism and urinary citrate excretion in recurrent renal calcium stone formers and normal controls.

Authors:  Naohiko Okamoto; Seiji Aruga; Shoji Matsuzaki; Satoru Takahashi; Kazuo Matsushita; Tadaichi Kitamura
Journal:  Int J Urol       Date:  2007-04       Impact factor: 3.369

10.  Association of vitamin D receptor gene polymorphism with urolithiasis.

Authors:  Saori Nishijima; Kimio Sugaya; Ayako Naito; Makoto Morozumi; Tadashi Hatano; Yoshihide Ogawa
Journal:  J Urol       Date:  2002-05       Impact factor: 7.450

View more
  13 in total

1.  Progressive renal papillary calcification and ureteral stone formation in mice deficient for Tamm-Horsfall protein.

Authors:  Yan Liu; Lan Mo; David S Goldfarb; Andrew P Evan; Fengxia Liang; Saeed R Khan; John C Lieske; Xue-Ru Wu
Journal:  Am J Physiol Renal Physiol       Date:  2010-06-30

2.  Urolithiasis in ankylosing spondylitis: Correlation with Bath ankylosing spondylitis disease activity index (BASDAI), Bath ankylosing spondylitis functional index (BASFI) and Bath ankylosing spondylitis metrology index (BASMI).

Authors:  Sasan Fallahi; Ahmad Reza Jamshidi; Farhad Gharibdoost; Mahdi I Mahmoud; Pedram Paragomi; Mohammad Hossein Nicknam; Elham Farhadi; Mostafa Qorbani
Journal:  Caspian J Intern Med       Date:  2012

3.  Urine proteomic analysis in cystinuric children with renal stones.

Authors:  Larisa Kovacevic; Hong Lu; David S Goldfarb; Yegappan Lakshmanan; Joseph A Caruso
Journal:  J Pediatr Urol       Date:  2015-05-29       Impact factor: 1.830

4.  Use of Google Insights for Search to track seasonal and geographic kidney stone incidence in the United States.

Authors:  Benjamin N Breyer; Saunak Sen; David S Aaronson; Marshall L Stoller; Bradley A Erickson; Michael L Eisenberg
Journal:  Urology       Date:  2011-04-03       Impact factor: 2.649

Review 5.  From crystalluria to kidney stones, some physicochemical aspects of calcium nephrolithiasis.

Authors:  Johannes M Baumann; Beat Affolter
Journal:  World J Nephrol       Date:  2014-11-06

6.  Association of TRPV5, CASR, and CALCR genetic variants with kidney stone disease susceptibility in Egyptians through main effects and gene-gene interactions.

Authors:  Fahmy T Ali; Eman M Abd El-Azeem; Hala F A Hekal; Mayada M El-Gizawy; Mohamed S Sayed; AbdAllah Y Mandoh; Ahmed F Soliman
Journal:  Urolithiasis       Date:  2022-09-11       Impact factor: 2.861

7.  Colony-stimulating factor-1 signaling suppresses renal crystal formation.

Authors:  Kazumi Taguchi; Atsushi Okada; Hiroshi Kitamura; Takahiro Yasui; Taku Naiki; Shuzo Hamamoto; Ryosuke Ando; Kentaro Mizuno; Noriyasu Kawai; Keiichi Tozawa; Kenichi Asano; Masato Tanaka; Ichiro Miyoshi; Kenjiro Kohri
Journal:  J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 10.121

8.  Lack of evidence for the association of ornithine decarboxylase (+316 G>A), spermidine/spermine acetyl transferase (-1415 T>C) gene polymorphisms with calcium oxalate stone disease.

Authors:  Ajda Coker-Gürkan; Serdar Arisan; Elif Damla Arisan; Narçin Palavan Unsal
Journal:  Biomed Rep       Date:  2013-10-21

9.  Expression of the gene encoding oxalate decarboxylase from Bacillus subtilis and characterization of the recombinant enzyme.

Authors:  Eunhye Lee; Byong Chang Jeong; Yong Hyun Park; Hyeon Hoe Kim
Journal:  BMC Res Notes       Date:  2014-09-03

10.  Crowdsourced direct-to-consumer genomic analysis of a family quartet.

Authors:  Manuel Corpas; Willy Valdivia-Granda; Nazareth Torres; Bastian Greshake; Alain Coletta; Alexej Knaus; Andrew P Harrison; Mike Cariaso; Federico Moran; Fiona Nielsen; Daniel Swan; David Y Weiss Solís; Peter Krawitz; Frank Schacherer; Peter Schols; Huangming Yang; Pascal Borry; Gustavo Glusman; Peter N Robinson
Journal:  BMC Genomics       Date:  2015-11-07       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.